Clinical trial results

Novartis has long been dedicated to informing the public about the results of its interventional trials for innovative products. Novartis launched the results website in 2005 becoming one of the first companies to publically post results from Phase 2b-4 interventional trials. The Novartis position evolved over time to include public disclosure of results from Phase 1- 2a interventional trials in patients.

Transparency position

Novartis is committed to the timely registration of trials and posting of results.

Clinical trial results

Clinical trials are fundamental to the development of innovative products

Drug development process

Drug development begins and ends with the patient.